This is a preprint.
A 4D transcriptomic map for the evolution of multiple sclerosis-like lesions in the marmoset brain
- PMID: 37808784
- PMCID: PMC10557631
- DOI: 10.1101/2023.09.25.559371
A 4D transcriptomic map for the evolution of multiple sclerosis-like lesions in the marmoset brain
Update in
-
4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis-like lesions.Science. 2025 Feb 28;387(6737):eadp6325. doi: 10.1126/science.adp6325. Epub 2025 Feb 28. Science. 2025. PMID: 40014701
Abstract
Single-time-point histopathological studies on postmortem multiple sclerosis (MS) tissue fail to capture lesion evolution dynamics, posing challenges for therapy development targeting development and repair of focal inflammatory demyelination. To close this gap, we studied experimental autoimmune encephalitis (EAE) in the common marmoset, the most faithful animal model of these processes. Using MRI-informed RNA profiling, we analyzed ~600,000 single-nucleus and ~55,000 spatial transcriptomes, comparing them against EAE inoculation status, longitudinal radiological signals, and histopathological features. We categorized 5 groups of microenvironments pertinent to neural function, immune and glial responses, tissue destruction and repair, and regulatory network at brain borders. Exploring perilesional microenvironment diversity, we uncovered central roles of EAE-associated astrocytes, oligodendrocyte precursor cells, and ependyma in lesion formation and resolution. We pinpointed imaging and molecular features capturing the pathological trajectory of WM, offering potential for assessing treatment outcomes using marmoset as a platform.
Conflict of interest statement
D.S.R. has received research funding from Abata and Sanofi, unrelated to the current study.
Figures
References
-
- McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA. 2021. Feb 23;325(8):765–79. - PubMed
-
- Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021. Aug;20(8):653–70. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous